Skip to main content
SpringerLink
Log in

Möglicherweise eine Option für mehrfach vorbehandelte Frauen mit HER2-positivem Brustkrebs

Duale HER2-Blockade und Antiangiogenese

  • neues aus der forschung
  • Published:
Info Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Falchook GS et al. Dual HER2 inhibition in combination with anti-VEGF treatment is active in heavily pretreated HER2-positive breast cancer. Ann Oncol. 2013;24(12):3004–11.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. http://www.springermedizin.de

    Doris Berger

Authors
  1. Doris Berger
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Berger, D. Möglicherweise eine Option für mehrfach vorbehandelte Frauen mit HER2-positivem Brustkrebs. Info Onkol. 16, 55 (2013). https://doi.org/10.1007/s15004-013-0688-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-013-0688-7

Search

Navigation